Factors associated with adherence to ARV treatment in people living with HIV/AIDS in a rural area (Koula-Moutou) in East Gabon

References

• Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (London, England), 15(9), 1181–1183. https://doi.org/10.1097/00002030-200106150-00015
   PubMed Web of Science ®Google Scholar
• Bastard, M., Fall, M. B., Laniece, I., Taverne, B., Desclaux, A., Ecochard, R., … Etard, J. F. (2011). Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 57(1), 55–61. https://doi.org/10.1097/QAI.0b013e318211b43b
   PubMed Web of Science ®Google Scholar
• Benjaber, K., Rey, J. L., & Himmich, H. (2005). Étude sur l’observance du traitement antirétroviral à Casablanca (Maroc). Medecine et Maladies Infectieuses, 35(7-8), 390–395. https://doi.org/10.1016/j.medmal.2005.04.009
   PubMedGoogle Scholar
• Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., Gee, P., & Peterson, G. M. (2016). Antiretroviral adherence and treatment outcomes among adult Ethiopian patients. AIDS Care, 28(8), 1018–1022. https://doi.org/10.1080/09540121.2016.1139039
   PubMed Web of Science ®Google Scholar
• Caron, M., Lekana-Douki, S. E., Makuwa, M., Obiang-Ndong, G. P., Biba, O., Nkoghe, D., & Kazanji, M. (2012). Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa. BMC Infectious Diseases, 12(1), 64. https://doi.org/10.1186/1471-2334-12-64
   PubMedGoogle Scholar
• Hachfi, W., Bellazreg, F., Bougmiza, I., Gloulou, O., Kaabia, N., Bahri, F., & Letaief, A. (2012). Adherence to antiretroviral therapy in HIV-infected patients in Sousse, Tunisia. Médecine et Santé Tropicales, 22, 105–107.
   PubMedGoogle Scholar
• Hayashi, K., Wood, E., Kerr, T., Dong, H., Nguyen, P., Puskas, C. M., … Milloy, M. J. (2016). Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: A prospective cohort study. BMC Infectious Diseases, 16(1), 455. https://doi.org/10.1186/s12879-016-1749-y
   PubMed Web of Science ®Google Scholar
• Iwuji, C., McGrath, N., Calmy, A., Dabis, F., Pillay, D., Newell, M. L., … Porter, K. (2018). Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: The ANRS 12249 TasP trial. Journal of the International AIDS Society, 21(6), e25112. https://doi.org/10.1002/jia2.25112
   PubMed Web of Science ®Google Scholar
• Mbopi-Keou, F. X., Djomassi, L. D., & Monebenimp, F. (2012). Descriptive aspects of HIV/AIDS in patients aged 50 years and over followed at the Treatment Center of Bafoussam - Cameroon. The Pan African Medical Journal, 12, 107. http://www.panafrican-med-journal.com/content/article/12/107/full
   Google Scholar
• Mongo-Delis, A., Mickala, P., Mombo, L. E., Bouedy, W. S., Etho Mengue, J. C., Itsonoganga, G. L., … Bisseye, C. (2016). Facteurs influençant la perte de vue et la mortalité chez les personnes vivant avec le VIH suivies au Centre de Traitement Ambulatoire de Koula-Moutou (Gabon) de 2005 à 2015. The Pan African Medical Journal, 24, 198. https://doi.org/10.11604/pamj.2016.24.198.9708
   Google Scholar
• Mouala, C., Roux, P., Okome, M., Sentenac, S., Okome, F., Nziengui, U., Olivier, S., Benjaber, K., & Rey, J. L. (2006). Assessment of compliance with ARV treatment in Africa. Médecine Tropicale, 66(6), 610–614.
   PubMedGoogle Scholar
• Mûnene, E., & Ekman, B. (2015). Association between patient engagement in HIV care and antiretroviral therapy medication adherence: Cross-sectional evidence from a regional HIV care center in Kenya. AIDS Care, 27(3), 378–386. https://doi.org/10.1080/09540121.2014.963020
   PubMed Web of Science ®Google Scholar
• Nziengui, U., Zamba, C., & Rey, J. L. (2006). Difficulties of the patients to undergo their ARV treatment at the Libreville outpatient health center, Gabon. Bulletin de la Société de Pathologie Exotique, 99(1), 23–27. https://doi.org/10.3185/pathexo2635
   PubMedGoogle Scholar
• PNL-IST-VIH/SIDA. (2014). Guide de prise en charge des personnes vivant avec le VIH et le SIDA au Gabon. Libreville: Ministère de la Santé.
   Google Scholar
• Ricci, G., Netto, E. M., Luz, E., Rodamilans, C., & Brites, C. (2016). Adherence to antiretroviral therapy of Brazilian HIV-infected children and their caregivers. The Brazilian Journal of Infectious Diseases, 20(5), 429–436. https://doi.org/10.1016/j.bjid.2016.05.009
   PubMed Web of Science ®Google Scholar
• Tegegne, A. S., Ndlovu, P., & Zewotir, T. (2018). Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study. BMC Infectious Diseases, 18(1), 83. https://doi.org/10.1186/s12879-018-2977-0
   PubMedGoogle Scholar
• Traoré, F. A., Sako, F. B., Keita, M., Tounkara, T. M., Soumah, M. M., Sylla, D., … Cisse, M. (2016). Tolérance et observance aux ARVs chez les personnes vivant avec le VIH suivies au service des maladies infectieuses de l’hôpital national Donka de Conakry, Guinée. Medecine d’Afrique Noire, 63, 333–337.
   Google Scholar
• UNAIDS. (2017). UNAIDS data 2017. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved from http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf
   Google Scholar